Case: Eisai Co., Ltd., et al., Petitioners v. Teva Pharmaceuticals USA, Inc., Through Its Gate Pharmaceuticals Division
Abbreviation: Eisai Co. v. Teva Pharmaceuticals USA, Inc.
Decision Date: 2011-06-13
Docket Number: No. 10-1070
Citation: 180 L. Ed. 2d 818
Volume: 180
Reporter: United States Supreme Court Reports, Lawyers' Edition
Court: Supreme Court of the United States
Jurisdiction: United States
Parties: Eisai Co., Ltd., et al., Petitioners v. Teva Pharmaceuticals USA, Inc., Through Its Gate Pharmaceuticals Division.
Judges: 
Pages: 818–819

Head Matter:
No. 10-1070.
Eisai Co., Ltd., et al., Petitioners v. Teva Pharmaceuticals USA, Inc., Through Its Gate Pharmaceuticals Division.
564 U.S. 1001, 131 S. Ct. 2991,
180 L. Ed. 2d 818,
2011 U.S. LEXIS 4519.
June 13, 2011.

Opinion:
On petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit. Petition for writ of certiorari granted. Judgment vacated, and case remanded to the United States Court of Appeals for the Federal Circuit with instructions to dismiss the case as moot. See United States v. Munsingwear, Inc., 340 U.S. 36, 71 S. Ct. 104, 95 L. Ed. 36 (1950).
Same case below, 620 F.3d 1341.